Pure Biologics

Pure Biologics, established in 2010 is the first company in Poland to invest in the development of novel biological  assets for therapeutic applications as well as diagnostics via two major product streams: Antibodies and Aptamers.  Utilizing our proprietary platforms, we undertake entire lifecycle of antibody and aptamer discovery and development; from selection, characterization and validation of the lead candidates aiming up to clinical trial Phase-1. As a CRO we extend our services to the customers in the field of production and purification of recombinant proteins and antibodies, early stage product development, protein engineering, protein formulation, genome sequencing, proteomic analysis and bioinformatics.

Contact details

purebiologics.com
Pure Biologics